September 04, 2013
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
FDA clears new assay for T. vaginalis
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The FDA has cleared the launch of a new assay to test samples for Trichomonas vaginalis, according to a press release.
The ProbeTec Trichomonas vaginalis Qx Amplified DNA Assay (BD Diagnostics) will be used in BD Diagnostic’s BD Viper System to detect T. vaginalis DNA in endocervical, vaginal and urine samples. This system is used by laboratories to test samples for T. vaginalis, Chlamydia trachomatis and Neisseria gonorrhoeae. It also can be used in batch mode to test for chlamydia and gonorrhea, trichomonas and herpes, according to a press release from the manufacturer.
Visit the FDA site for more information.